Click on a description to go to the original article.

INRG Project Number Investigators Description Publication/Abstract
2006-01 Dubois SG, London WB, Zhang Y, Matthay KK, Monclair T, Ambros PF, Cohn SL, Pearson A, Diller L. Lung metastases in neuroblastoma at initial diagnosis Pediatr Blood Cancer. 2008 Nov;51(5):589-92
2006-02 Meany HJ, London WB, Ambros PF, Matthay KK, Monclair T, Simon T, Garaventa A, Berthold F, Nakagawara A, Cohn SL, Pearson AD, Park JR. Outcome for stage 3 neuroblastoma Pediatr Blood Cancer. 2014 Nov;61(11):1932-9.
2006-03 Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma J Clin Oncol. 2009 Jan 20;27(3):365-70
2007-01 Mossé YP, Deyell RJ, Berthold F, Nagakawara A, Ambros PF, Monclair T, Cohn SL, Pearson AD, London WB, Matthay KK Neuroblastoma Neuroblastoma in older children, adolescents and young adults Pediatr Blood Cancer. 2013 Sep 13. doi: 10.1002/pbc.24777
2007-02 Hiyama Research Project for Evaluation of Japanese Mass Screening Program Data collection ongoing
2007-03 Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, Haber M, Khan J, Nakagawara A, Speleman F, Noguera R, Tonini GP, Fischer M, Ambros I, Monclair T, Matthay KK, Ambros P, Cohn SL, Pearson AD Segmental chromosomal alterations have prognostic impact in neuroblastoma Br J Cancer. 2012 Oct 9;107(8):1418-22
2008-01 Taggart DR, London WB, Schmidt ML, DuBois SG, Monclair TF, Nakagawara A, De Bernardi B, Ambros PF, Pearson AD, Cohn SL, Matthay KK. Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age J Clin Oncol. 2011 Nov 20;29(33):4358-64
2008-02 Angelini P, London WB, Cohn SL, Pearson AD, Matthay KK, Monclair T, Ambros PF, Shimada H, Leuschner I, Peuchmaur M, Irwin MS, Baruchel S Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype Eur J Cancer. 2012 May;48(8):1185-91
2008-03 London WB, Castel V, Monclair T, Ambros PF, Pearson AD, Cohn SL, Berthold F, Nakagawara A, Ladenstein RL, Iehara T, Matthay KK. Clinical and biologic features predictive of survival after relapse of neuroblastoma J Clin Oncol. 2011 Aug 20;29(24):3286-92
2009-02 Moroz V, Machin D, Faldum A, Hero B, Iehara T, Mosseri V, Ladenstein R, De Bernardi B, Rubie H, Berthold F, Matthay KK, Monclair T, Ambros PF, Pearson AD, Cohn SL, London WB. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma Eur J Cancer. 2011 Mar;47(4):561-71
2010-01 Cohn / Pearson / London The Role of Race and Ethnicity in Neuroblastoma Data collection ongoing
2011-01 George S, Lipsitz E, Deyell R, Maris JM, Hero B, Pearson ADJ, Machin D Investigation of Patients with Neuroblastoma with Central Nervous System Metastases at Diagnosis Data collection ongoing
2012-01 Morgenstern DA, London WB, Stephens D, Volchenboum SL, Hero B, Di Cataldo A, Nakagawara A, Shimada H, Ambros PF, Matthay KK, Cohn SL, Pearson AD, Irwin MS. Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: a study from the International Neuroblastoma Risk Group (INRG) database J Clin Oncol. 2014 Apr20:32 (12):1228-35
2013-01 Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG. Biologic, clinical, and prognostic differences based upon primary site of origin in neuroblastoma J Clin Oncol. 2014 Oct 1;32(28):3169-76.
2013-02 Kirby C, Andrade J, Huang L, Nakazawa A, Matthay KK, Ambros PF, Leuschner I, Park JR, London WB, Pearson ADJ, Cohn SL, Volchenboum SL Gene expression analysis of neuroblastoma tumors according to MKI and differentiation status Presented at ANR 2014
2013-03 London WB, Moroz V, Hero B, Park J, Valteau-Couanet D, Nakagawara A, Berthold F, Matthay KK, Ambros PF, Pearson ADJ, Cohn SL, Machin D Risk Stratification Using Clinical Factors, For Treatment of Neuroblastoma Patients in Developing Countries Presented at ANR 2014
2014-01 Morgenstern D, London WB, Stephens D, Volchenboum SL, Simon T, Nakagawara A, Shimada J, Ambros PF, Matthay KK, Cohn SL, Pearson ADJ, Irwin M Prognostic significance of specific metastatic sites in patients with stage 4 neuroblastoma Submitted to Eur J Cancer
2014-02 Applebaum MA, Vaksman Z, Lee SM, Hungate EA, Henderson TO, London WB, Pinto N, Volchenboum SL, Park JR, Naranjo A, Hero B, Pearson AD, Stranger BE, Cohn SL, Diskin SJ Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project. Eur J Cancer. 2017 Feb;72:177-185. doi: 10.1016/j.ejca.2016.11.022
2014-03 Thompson D, Vo KT, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK, DuBois SG Independent predictors of MYCN amplification in neuroblastoma Cancer 2016 Mar 15;122(6):935-45.
2015-01 Thompson D, Vo KT, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK, DuBois SG Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer. 2015 Dec 28. doi: 10.1002/cncr.29848
2015-02 Moreno L, Pearson ADJ, Guo D, Morgenstern D, Pasqualini C, Ash S, Valteau-Couanet D, Cohn SL, London WB Predicting early relapse/progression death in children with stage M neuroblastoma Data collection ongoing